Germany July 25, 2011
- 353.7 Million Euros
- 51.1 Million Euros
- Management Raises Full-Year Guidance for Sales Revenue and Profit
Based on the company’s successful first half, management raised its 2011 full-year guidance for sales revenue and profit. Consolidated sales revenue is thus expected to grow on the basis of constant currencies from 6.4% in 2010 to between 8% and 10% (former guidance: 6% to 8%). The operating margin is forecasted to increase from 13.0% in 2010 to between 14.5% and 15.5% (former guidance: around 14%).
Development of Order Intake and Sales Revenue
382.3 million euros 353.7 million euros
257.2 million euros 229.4 million euros 125.1 million euros 124.3 million euros
Asia/Pacific 80.1 million euros Asia/Pacific Europe North America
51.1 million euros
38.6 million euros 4.8 million euros to 12.4 million euros
24.0 million euros 15.9 million euros 3.8 million euros 3.5 million euros 1.41 euros 0.93 euro
"In the first half, we again overproportionately increased our earnings. What is especially encouraging is the strong gain in profitability reported by the Mechatronics Division. This development underscores the good market positioning and successful business model of both divisions. Based on our excellent first-half results, we have raised our forecasts for sales revenue and earnings for both divisions and, therefore, for the entire Group," commented Dr. Kreuzburg.
– – –
* Earnings before interest, taxes and amortization and adjusted for extraordinary expenses = underlying EBITA
According to its guidance now raised, Sartorius expects 2011 full-year sales for both divisions, and thus for the entire Group, to grow 8% to 10% in constant currencies (former guidance: 6% to 8%). At the same time, it projects that the increase in profitability will be stronger. The operating EBITA margin at Group level is forecasted to rise to 14.5% to 15.5% (former guidance: around 14%). The Biotechnology Division is expected to contribute an operating margin of approximately 17% to 18% (former guidance: around 17%) and the Mechatronics Division a margin of around 10% to 11% (former guidance: about 8%) to this result. Furthermore, management continues to anticipate that operating cash flow will be significantly positive.
Key Figures at a Glance
EUR in millions (unless otherwise Biotechnology Mechatronics specified) Sartorius Group Division Division 1st 1st 1st 1st 1st 1st half half Change half half Change half half Change of of of of of of 2011 2010 in % 2011 2010 in % 2011 2010 in % Order intake 382.3 336.4 13.6 257.2 221.4 16.2 125.1 115.1 8.7 Sales revenue 353.7 315.2 12.2 229.4 209.1 9.7 124.3 106.1 17.2 EBITA 1) 51.1 36.3 40.7 38.6 31.5 22.8 12.4 4.8 157.5 EBITA margin 1) 14.4% 11.5% 16.8% 15.0% 10.0% 4.5% Extraordinary expenses/income 6.7 1.9 2.9 0.5 3.7 1.4 Net profit 1)2) 24.0 15.9 50.6 Earnings per share in EUR 1)2) 1.41 0.93 50.6
Current Image Files :
Sartorius | Biotechnology Division (Sartorius Stedim Biotech):
Sartorius | Mechatronics Division:
Conference Call and Webcast:
Joachim Kreuzburg July 25, 2011 4:00 p.m. 3:45 p.m. CET
Upcoming Financial Date:
October 2011 September 2011
This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.
This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.
A Profile of Sartorius
659.3 million euros Europe Asia
Petra Kirchhoff, Vice President of Group Corporate Communications
Sartorius Corporate Administration GmbH; 37070 Goettingen , Germany
SOURCE Sartorius AG